Highlights the necessity of a multidisciplinary approach, complete device removal, and prolonged antibiotic therapy for managing cardiac device infections.
Answers are grounded in this paper and cite their sources.
May reinforce multidisciplinary management of cardiac device infections; leaves open the need for prospective trials to optimize protocols.
The use of implantable devices in management of cardiac diseases is increasing as a result of improvements in technology of permanent pacemaker and implantable cardioverter defibrillators. Device related infections are also rising accordingly and have become an important clinical problem. Accurate diagnosis and optimal management of these infections is challenging, necessitating complete removal of the device and prolonged antibiotic therapy. In this regard, a multidisciplinary approach is required with the essential support of microbiology and imaging modalities. This paper highlights the current literature on the pathogenesis, risk factors, diagnosis and management of device related infections.
No takes yet. Share an insight, caveat, or question.
Kafes et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: